Sentences with phrase «of psychedelic research»

Ram Dass» interests include the support of psychedelic research, international development, environmental awareness and political action.

The history of psychedelic research includes many serious scientists but also many inflated claims about the benefits of the substances.

Not exact matches

Other charities that have benefited from the organization include healthcare outsourcing platform Watsi; The Water Project; the Electronic Frontier Foundation digital - rights activism group; MAPS, an organization that studies therapeutic uses of psychedelic drugs and marijuana; the medical nonprofit SENS Research Foundation; and charity: water.

Michael Pollan and Psychedelics — one of my favorite modern - day writers on the new, fascinating research in the field of Psychedelics — one of my favorite modern - day writers on the new, fascinating research in the field of psychedelicspsychedelics

In the current climate, the main source of funding for studies of hallucinogens are two private philanthropies: the Heffter Research Institute in Santa Fe, which was founded in 1993 by academics and mental health professionals to finance scholarly research, and MAPS (Multidisciplinary Association for Psychedelic Studies), which has dispensed more than $ 10 million since it was launched in 1986 by Rick Doblin, a drug reform activist in Boston with a Harvard University Ph.D. in publicResearch Institute in Santa Fe, which was founded in 1993 by academics and mental health professionals to finance scholarly research, and MAPS (Multidisciplinary Association for Psychedelic Studies), which has dispensed more than $ 10 million since it was launched in 1986 by Rick Doblin, a drug reform activist in Boston with a Harvard University Ph.D. in publicresearch, and MAPS (Multidisciplinary Association for Psychedelic Studies), which has dispensed more than $ 10 million since it was launched in 1986 by Rick Doblin, a drug reform activist in Boston with a Harvard University Ph.D. in public policy.

«If you were to develop a drug to treat PTSD, you'd want it to do exactly what MDMA does,» says Rick Doblin, founder and executive director of the Multidisciplinary Association for Psychedelic Studies (MAPS), which funds and conducts the research.

At a handful of sites across the country, after a four - decade hiatus, psychedelic research is undergoing a quiet renaissance, thanks to scientists like Charles Grob who are revisiting the powerful mind - altering drugs of the 1960s in hopes of making them part of our therapeutic arsenal.

With the realization of possible therapeutic benefits of psychedelics to reduce anxiety and chronic pain, however, the societal taboos against scientific research on their neurobiology have somewhat relaxed.

Four decades ago the federal government shut down most research on psychedelics, and the Journal of the American Medical Association warned that they can cause permanent «personality deterioration,» even in previously healthy users.

«I was so fascinated that I did all this research,» says Halpern, who had never taken psychedelics and knew little of their history.

While research on the benefits of psychedelic drugs took place in the 1950 to the 1970s, primarily to treat mental illness, it was stopped due to the reclassification of the drugs to a controlled substance in the mid-1970s.

«What we have done in this research is begin to identify the biological basis of the reported mind expansion associated with psychedelic drugs,» said Dr Robin Carhart - Harris from the Department of Medicine, Imperial College London.

Halpern's conviction that psychedelics might help alcoholics and addicts is based both on research by others and on his personal observations of members of the Native American Church.

By the early 1980s, the DMT theory of psychosis was largely abandoned when psychedelic research involving humans became too controversial.

This led me to pursue formal education and training in psychiatric pharmacy as well as public health, which further inspired me to be involved in researching the utility of psychedelic substances in the treatment of illness,» explained study author Benjamin J. Malcolm of Western University of Health Sciences» College of Pharmacy.

The new wave of research on psychedelics — «version 2.0,» as Dr. Ross calls it — began in the early 1990s, when the Food and Drug Administration (FDA) sanctioned a few preliminary studies on psilocybin and MDMA.

He claims his own research shows that microdosing the drug «has no psychedelic effects, has proved helpful for a variety of conditions, and seems to help healthy people function better as well,» he told Health.

In 1961, while at Harvard, Ram Dass» explorations of human consciousness led him, in collaboration with Timothy Leary, Ralph Metzner, Aldous Huxley, Allen Ginsberg, and others, to pursue intensive research with psilocybin, LSD - 25, and other psychedelic chemicals.

Out of this research came two books: The Psychedelic Experience (co-authored by Leary and Metzner, and based on The Tibetan Book of the Dead); and LSD (with Sidney Cohen and Lawrence Schiller).

The non-profit leading the research, the Multidisciplinary Association for Psychedelic Studies (MAPS), is seeking $ 25 mln in donations for Phase 3 of their drug trials.

Video Preview of 549 Developments in Psychedelic Psychotherapy with Dr. Ben Sessa - Shrink Rap Radio Psychology Interviews: Exploring brain, body, mind, spirit, intuition, leadership, research, psychotherapy and more!